BOSTON, March 28, 2024 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that on March 28, 2024, the company granted equity awards to six new employees, pursuant…
Introduction Last year, I started covering healthcare giant Johnson & Johnson (NYSE:JNJ), with my most recent article on the company…
The Office of Management and Budget on Thursday announced changes to how the federal government asks about people’s race and…
The closure of the Port of Baltimore to shipping traffic following a container ship’s collision with a bridge that collapsed…
Investors are refusing to inject billions in new money into Britain’s biggest water company, leaving the beleaguered business at risk…
Last updated: March 28, 2024 15:33 EDT | 5 min read In wake of its latest price pump, profit-taking Dogecoin…
Andrew Woodcock took the government agency to an employment tribunal in an attempt to claim back the lunch money he…
The new group will be managed by the Independent, with staff from…
Editor's Pick
House Oversight Chairman James Comer officially invited President Joe Biden to testify at a…
Just In
A man in his 40s has been arrested on suspicion of attempted…
Finance
There’s a cheap and simple way to deter cats from your garden – as they never like to use their own garden to go…
The Government climbdown follows a backlash from Tory MPs – including some…
The Boots Beauty Easter Egg is back for 2024 and is worth…
Buying a pallet of Amazon returns is always a risk as you…
Business
Editor’s Note: A version of this article first appeared in the “Reliable Sources” newsletter. Sign up for the daily digest chronicling the…
Investing
Hot Topics
On Friday, March 29, 2024 at 8:30 AM US EST, the Bureau…
Economy
For the first time in decades, Trader Joe’s has increased the price…
Markets
On Monday, Guggenheim maintained its Buy rating on Constellation Energy Corporation (NASDAQ:CEG)…